TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/19/2022
Back to search
Official data from USPTO
DETECTWISE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DETECTWISE
ST13
US500000088891709Class
9, 42, 44
Filing
88891709
Registration
6715043
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
05/19/2022
Trademark type
Word
Nice classes
9, 42, 44
Filing date
04/28/2020
Registration date
05/03/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/03/2022
Last transaction
05/03/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/04/2020
First use in commerce
05/04/2020
Drawing code
4
Owner type
03
Owner location
Centreville, VA
Examiner
KUNG, KAELIE
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
P. C. (pessoa física)
Representatives
Blade Metzer Parsons Corporation, Legal
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Telethermographic testing systems sold as a unit comprised of thermal imaging camerasinfrared camerascomputer hardware and recorded computer software for purposes of collectinganalyzingdisplaying information to help identify and prevent the spread of infectious diseases; biometric testing systems comprised of biometric scanners; systems comprised of downloadable electronic health assessment application questionnaires that use artificial intelligence analyticsdownloadable and recorded computer software and user interfaces for end-users being touchscreens for electrotechnical and electronic devicesdownloadable and recorded computer software that automates reportingrisk analyticsto measureanalyze and detect indicia ofpossible exposure toinfectious diseases and viruses onsite at public facilitiescommercial facilitiesprivate facilitiestransportation facilitiesairportsentertainment and sports facilitieswork facilitiesoffice buildingsrestaurants and food outletsretail facilitiesshopping mallsmanufacturing facilitieshospitalsother government ownedcommercialretail and residential facilities
Class 42
Providing medical testing service in the field of infectious disease research and infectious disease classification to help prevent the spread of infectious diseases
Class 44
Medical testing to assist in the diagnosis or treatment of infectious diseasesnamely biological on-site testing; medical testing for diagnostic and/or reporting purposes; on-site medical testing for diagnostic or treatment purposes relating to infectious diseasesproviding on-site medical testing and medical consultation facilities for preventing the spread of infectious diseases; medical analysis services for diagnostic and treatment purposes provided by on-site medical laboratories for infectious diseases; on-site medical testingtemperature testingblood pressure testingpulse rate testing and other testing for purposes of identifying and preventing the spread of infectious diseases; providing medical testing facilities utilizing telethermographic testing systemsproviding medical testing facilities utilizing biometric testing systemstesting centers located on-site at public facilitiescommercial facilitiesprivate facilitiestransportation facilitiesairportsentertainment and sports facilitieswork facilitiesoffice buildingsrestaurants and food outletsretail facilitiesshopping mallsmanufacturing facilitieshospitalsother government ownedcommercialretail and residential facilities for purposes of identifying and preventing the spread of infectious diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories located on-site at public facilitiescommercial facilitiesprivate facilitiestransportation facilitiesairportsentertainment and sports facilitieswork facilitiesoffice buildingsrestaurants and food outletsretail facilitiesshopping mallsmanufacturing facilitieshospitalsother government ownedcommercialretail and residential facilities for purposes of identifying and preventing the spread of infectious diseases; onsite virus testing at a mass scalebeing medical testing for diagnostic or treatment purposes; providing on-site virus and infectious disease medical testing facilities with positive and negative ventilation control with filtration systems to avoid patient and worker transmission; providing walk-up and drive-through infectious disease medical testing facilities; providing modular medical testing facilities for infectious diseases for use on site at public facilitiescommercial facilitiesprivate facilitiestransportation facilitiesairportsentertainment and sports facilitieswork facilitiesoffice buildingsrestaurants and food outletsretail facilitiesshopping mallsmanufacturing facilitieshospitalsother government ownedcommercialretail and residential facilities; providing in-person health screening services and turn-key health assessment services at public facilitiescommercial facilitiesprivate facilitiestransportation facilitiesairportsentertainment and sports facilitieswork facilitiesoffice buildingsrestaurants and food outletsretail facilitiesshopping mallsmanufacturing facilitieshospitalsother government ownedcommercialretail and residential facilities for purposes of identifying potential exposure to and carriers of infectious diseases and viruses and to prevent the spread of infectious diseases; providing modular facilities for on-site testing for infectious diseases for medical diagnostic or treatment purposes; providing mobile modular testing facilities for use in performing on-site testing for medical diagnostic or treatment purposes to prevent the spread of infectious diseases; providing modular testing facilities for on-site virus and infectious disease testing for medical diagnostic or treatment purposes with positive and negative ventilation control with filtration systems to avoid patient and worker transmission; providing modular testing facilities for walk-up and drive-through infectious disease testing for medical diagnostic or treatment purposesevaluation and analysis; providing modular testing facilities for infectious diseases for medical diagnostic or treatment purposes for use on site at public facilitiescommercial facilitiesprivate facilitiestransportation facilitiesairportsentertainment and sports facilitieswork facilitiesoffice buildingsrestaurants and food outletsretail facilitiesshopping mallsmanufacturing facilitieshospitalsother government ownedcommercialretail and residential facilities; Providing mobile modular medical laboratory facilities to provide in-person infectious disease screening services for diagnostic purposesproviding mobile modular sanitary installations with thermal imaging for dispensing antiseptic and antiviral agents for self-decontamination and for issuing personal protective gearall located on-site at public facilitiescommercial facilitiesprivate facilitiestransportation facilitiesairportsentertainment and sports facilitieswork facilitiesoffice buildingsrestaurants and food outletsretail facilitiesshopping mallsmanufacturing facilitieshospitalsother government ownedcommercialretail and residential facilities for purposes of identifying and preventing the spread of infectious diseases
Publications
History of USPTO decisions and trademark events.
50 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/19/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/03/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/15/2022
PUBO
PUBLISHED FOR OPPOSITION
02/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/12/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/10/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/08/2022
GNRT
NON-FINAL ACTION E-MAILED
01/08/2022
CNRT
NON-FINAL ACTION WRITTEN
01/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/16/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/15/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/25/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/25/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/25/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/25/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/25/2021
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
06/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/08/2021
GNRT
NON-FINAL ACTION E-MAILED
06/08/2021
CNRT
NON-FINAL ACTION WRITTEN
06/08/2021
IUAA
USE AMENDMENT ACCEPTED
06/08/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/05/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/05/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/05/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/05/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/05/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/05/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/05/2021
ALIE
ASSIGNED TO LIE
04/30/2021
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
01/16/2021
IUAF
USE AMENDMENT FILED
01/16/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/15/2021
EAAU
TEAS AMENDMENT OF USE RECEIVED
01/15/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/11/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
09/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/11/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/11/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/17/2020
GNRT
NON-FINAL ACTION E-MAILED
07/17/2020
CNRT
NON-FINAL ACTION WRITTEN
07/17/2020
DOCK
ASSIGNED TO EXAMINER
07/13/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/11/2020
NWAP
NEW APPLICATION ENTERED
05/01/2020
Continuous trademark protection
Get notified about every new filing that threatens DETECTWISE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.